Ítem
Solo Metadatos
Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
dc.creator | Bermudez, Adriana | |
dc.creator | Calderon, Dayana | spa |
dc.creator | Moreno-Vranich, Armando | spa |
dc.creator | Almonacid, Hannia | spa |
dc.creator | Patarroyo, Manuel A. | spa |
dc.creator | Poloche, Andrés | spa |
dc.creator | Patarroyo, Manuel E. | spa |
dc.date.accessioned | 2020-05-26T00:02:14Z | |
dc.date.available | 2020-05-26T00:02:14Z | |
dc.date.created | 2014 | spa |
dc.description.abstract | Topological and stereo-electron characteristics are essential in major histocompability class II-peptide-T-cell receptor (MHC-p-TCR) complex formation for inducing an appropriate immune response. Modified high activity binding peptides (mHABPs) were synthesised for complete full protection antimalarial vaccine development producing a large panel of individually fully protection-inducing protein structures (FPIPS) and very high long-lasting antibody-inducing (VHLLAI) mHABPs. Most of those which did not interfere, compete, inhibit or suppress their individual VHLLAI or FPIPS activity contained or displayed a polyproline II-like (PPIIL) structure when mixed. Here we show that amino acid side-chains located in peptide binding region (PBR) positions p3 and p7 displayed specific electron charges and side-chain gauche+ orientation for interacting with the TCR. Based on the above, and previously described physicochemical principles, non-interfering, long-lasting, full protection-inducing, multi-epitope, multistage, minimal subunit-based chemically synthesised mHABP mixtures can be designed for developing vaccines against diseases scourging humankind, malaria being one of them. © 2014 Elsevier Ltd. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1016/j.vaccine.2014.02.003 | |
dc.identifier.issn | 0264410X | |
dc.identifier.issn | 13588745 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/23461 | |
dc.language.iso | eng | spa |
dc.publisher | Elsevier BV | spa |
dc.relation.citationEndPage | 2126 | |
dc.relation.citationIssue | No. 18 | |
dc.relation.citationStartPage | 2117 | |
dc.relation.citationTitle | Vaccine | |
dc.relation.citationVolume | Vol. 32 | |
dc.relation.ispartof | Vaccine, ISSN:0264410X, 13588745, Vol.32, No.18 (2014); pp. 2117-2126 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896548606&doi=10.1016%2fj.vaccine.2014.02.003&partnerID=40&md5=c760298d7f029fff1752b8dc316cca14 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | protozoan | eng |
dc.subject.keyword | Peptide vaccine | spa |
dc.subject.keyword | Unclassified drug | spa |
dc.subject.keyword | Very high long lasting antibody inducing modified high activity binding peptide | spa |
dc.subject.keyword | Animal experiment | spa |
dc.subject.keyword | Antibody production | spa |
dc.subject.keyword | Antibody titer | spa |
dc.subject.keyword | Aotus | spa |
dc.subject.keyword | Article | spa |
dc.subject.keyword | Controlled study | spa |
dc.subject.keyword | Drug mixture | spa |
dc.subject.keyword | Enzyme linked immunosorbent assay | spa |
dc.subject.keyword | Gauche side chain orientation | spa |
dc.subject.keyword | Genotype | spa |
dc.subject.keyword | Immune response | spa |
dc.subject.keyword | Immunofluorescence | spa |
dc.subject.keyword | Immunogenicity | spa |
dc.subject.keyword | Nonhuman | spa |
dc.subject.keyword | Priority journal | spa |
dc.subject.keyword | Protection | spa |
dc.subject.keyword | Protein structure | spa |
dc.subject.keyword | Proton nuclear magnetic resonance | spa |
dc.subject.keyword | Sporozoite | spa |
dc.subject.keyword | Vaccination | spa |
dc.subject.keyword | Western blotting | spa |
dc.subject.keyword | Antimalarial vaccine | spa |
dc.subject.keyword | Gauche(+) | spa |
dc.subject.keyword | Peptide mixtures | spa |
dc.subject.keyword | Protective immunity | spa |
dc.subject.keyword | ?(1) angle | spa |
dc.subject.keyword | Adjuvants | eng |
dc.subject.keyword | Amino acid sequence | spa |
dc.subject.keyword | Animals | spa |
dc.subject.keyword | Antibodies | eng |
dc.subject.keyword | Antibody formation | spa |
dc.subject.keyword | Aotus trivirgatus | spa |
dc.subject.keyword | Binding sites | spa |
dc.subject.keyword | Hla-dr beta-chains | spa |
dc.subject.keyword | Malaria vaccines | spa |
dc.subject.keyword | Malaria | eng |
dc.subject.keyword | Molecular sequence data | spa |
dc.subject.keyword | Oligopeptides | spa |
dc.subject.keyword | Protein conformation | spa |
dc.subject.keyword | Antimalarial vaccine | spa |
dc.subject.keyword | Peptide mixtures | spa |
dc.subject.keyword | Protective immunity | spa |
dc.title | Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |